Literature DB >> 9296087

Tetracycline-resistant Chlamydia trachomatis in Toulouse, France.

J C Lefevre1, J P Lepargneur, D Guion, S Bei.   

Abstract

We report the first isolation of a tetracycline-resistant Chlamydia trachomatis strain in Toulouse, France. Culture of a post treatment endocervical specimen from a woman treated with tetracycline grew C. trachomatis. The patient was retreated with pristinamycin and cured. The minimal inhibitory concentration (MIC) and the minimal bactericidal concentration (MBC) of tetracycline for the patient isolate were > 64 micrograms/ml although 1% of the population of organisms showed resistance. Conversely for 34 C. trachomatis isolates recovered since 1988 from patients before treatment, in Toulouse, all the MICs of tetracycline were < or = 0.25 microgram/ml. If the isolation of tetracycline-resistant C. trachomatis was the result of persisting organisms, the management of chlamydial infections could be changed.

Entities:  

Mesh：

Year:  1997        PMID： 9296087

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN： 0369-8114


  9 in total

Review 1.  Antibiotic resistance in Chlamydiae.

Authors:  Kelsi M Sandoz; Daniel D Rockey
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

2.  Fitness cost due to mutations in the 16S rRNA associated with spectinomycin resistance in Chlamydia psittaci 6BC.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance.

Authors:  I Chopra; M Roberts
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

4.  Frequency of spontaneous mutations that confer antibiotic resistance in Chlamydia spp.

Authors:  Rachel Binet; Anthony T Maurelli
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

5.  Methodologies and cell lines used for antimicrobial susceptibility testing of Chlamydia spp.

Authors:  R J Suchland; W M Geisler; Walter E Stamm
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

6.  Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.

Authors:  R J Suchland; K M Sandoz; B M Jeffrey; W E Stamm; D D Rockey
Journal:  Antimicrob Agents Chemother       Date:  2009-08-17       Impact factor: 5.191

7.  Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing.

Authors:  Simon R Harris; Ian N Clarke; Helena M B Seth-Smith; Anthony W Solomon; Lesley T Cutcliffe; Peter Marsh; Rachel J Skilton; Martin J Holland; David Mabey; Rosanna W Peeling; David A Lewis; Brian G Spratt; Magnus Unemo; Kenneth Persson; Carina Bjartling; Robert Brunham; Henry J C de Vries; Servaas A Morré; Arjen Speksnijder; Cécile M Bébéar; Maïté Clerc; Bertille de Barbeyrac; Julian Parkhill; Nicholas R Thomson
Journal:  Nat Genet       Date:  2012-03-11       Impact factor: 38.330

8.  Functional inhibition of acid sphingomyelinase disrupts infection by intracellular bacterial pathogens.

Authors:  Chelsea L Cockburn; Ryan S Green; Sheela R Damle; Rebecca K Martin; Naomi N Ghahrai; Punsiri M Colonne; Marissa S Fullerton; Daniel H Conrad; Charles E Chalfant; Daniel E Voth; Elizabeth A Rucks; Stacey D Gilk; Jason A Carlyon
Journal:  Life Sci Alliance       Date:  2019-03-22

Review 9.  Genital Chlamydia trachomatis: an update.

Authors:  Meenakshi Malhotra; Seema Sood; Anjan Mukherjee; Sumathi Muralidhar; Manju Bala
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.